Promoting and supporting leadership in hematology departments by Roch Houot, Emmanuel Gyan

Get full text

Comment to "Sequencing of cellular therapy and bispecific antibodies for the management of diffuse large B-cell lymphoma": chimeric antigen receptor T-cell therapy remains effectiv... by Gilles Crochet, Roch Houot

Get full text

Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy by Marie de Charette, Roch Houot

Get full text

Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation by Guillaume Manson, Pauline Brice, Charles Herbaux, Kamal Bouabdallah, Chloé Antier, Florence Poizeau, Laurent Dercle, Roch Houot

Get full text

Discordant Response of Systemic Mastocytosis Associated With Myelodysplastic Syndrome After Midostaurin and Allogeneic Hematopoietic Stem-cell Transplantation by Marion Haas, Roch Houot, Francisco Llamas-Gutierrez, Marie-Laure Boulland, Mikael Roussel, Thierry Lamy, Thierry Fest, Cedric Pastoret

Get full text

Postoperative stage 0 Hodgkin lymphoma. Is surgery alone a curative option? by Audrey Couturier, Alexandra Judet, Mohamed Touati, Thomas Nivet, Pierre Daufresne, Fabien Claves, Eric Durot, Rémy Duléry, Roch Houot, Guillaume Manson

Get full text

Parkinson‐like neurotoxicity in female patients treated with idecabtagene‐vicleucel by Audrey Couturier, Martine Escoffre, Frédérique Leh, Anne‐Sophie Villoteau, Xavier Palard, Florence Le Jeune, Olivier Decaux, Thierry Lamy, Roch Houot

Get full text

Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for... by Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, Lucie Oberic, Olivier Chinot, Franck Morschhauser, Frédéric Peyrade, Roch Houot, Khê Hoang-Xuan, Hervé Ghesquieres, Carole Soussain

Get full text

Features and outcomes of patients admitted to the ICU for chimeric antigen receptor T cell-related toxicity: a French multicentre cohort by Corentin Le Cacheux, Audrey Couturier, Clara Sortais, Roch Houot, Morgane Péré, Thomas Gastinne, Amélie Seguin, Jean Reignier, Jean-Baptiste Lascarrou, Jean-Marc Tadié, Quentin Quelven, Emmanuel Canet

Get full text

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagn... by Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, Lucie Oberic, Olivier Chinot, Franck Morschhauser, Frédéric Peyrade, Roch Houot, Khê Hoang-Xuan, Hervé Ghesquieres, Carole Soussain

Get full text

Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapy by Ranjit Nair, Gaëlle Drillet, Faustine Lhomme, Anthony Le Bras, Laure Michel, John Rossi, Marika Sherman, Allen Xue, Anne Kerber, Nutchawan Jittapiromsak, Linda Chi, Sudhakar Tummala, Sattva S. Neelapu, Roch Houot

Get full text

P1687: LIFE AFTER CAR T-CELLS: DO PATIENTS RECOVER A NORMAL LIFE? by Alya Perthus, Fanny Colin, Emilie Charton, Amelie Anota, Sophie De Guibert, Loïc Ysebaert, Pierre Daufresne, Faustine Lhomme, Guillaume Manson, Adeline Bellec, Laetitia Le Bars, Thierry Lamy De La Chapelle, Roch Houot, Aline Moignet

Get full text

P1407: REMOTE MONITORING OF CAR T-CELL TREATED PATIENTS BY A SPECIALIZED NURSE TO DETECT AND MANAGE LATE COMPLICATIONS: REPORT OF THE CARAMA PROGRAM by Fanny Colin, Bellec Adeline, Laetitia Le Bars, Magali Granger, Sophie De Guibert, Guillaum Manson, Faustine Lhomme, Tony Marchand, Jean-Baptiste Mear, Martine Escoffre, Olivier Decaux, Thierry Lamy De La Chapelle, Roch Houot, Aline Moignet

Get full text

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma by Emmanuel Bachy, Roch Houot, Franck Morschhauser, Anne Sonet, Pauline Brice, Karim Belhadj, Guillaume Cartron, Bruno Audhuy, Christophe Fermé, Pierre Feugier, Catherine Sebban, Vincent Delwail, Hervé Maisonneuve, Steven Le Gouill, Sophie Lefort, Nicole Brousse, Charles Foussard, Gilles Salles

Get full text

Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy by Jennifer L. Crombie, Caron A. Jacobson, Robert Redd, Geoffrey Shouse, Alex F. Herrera, Victor A. Chow, Jordan Gauthier, Erin Mullane, Kirk Cahill, Justin Kline, Jason Romancik, Jonathon B. Cohen, Anna Saucier, Roch Houot, Philippe Armand, Brian Hess

Get full text

IGHV segment utilization in immunoglobulin gene rearrangement differentiates patients with anti-myelin-associated glycoprotein neuropathy from others immunoglobulin M-gammopathies by Jean-Sebastien Allain, Florian Thonier, Morgane Pihan, Marie-Laure Boulland, Sophie de Guibert, Vincent Launay, Anne-Violaine Doncker, Michel Ganard, Amyra Aliouat, Céline Pangault, Roch Houot, Marie De Tayrac, Thierry Lamy, Mikael Roussel, Thierry Fest, Olivier Decaux, Cedric Pastoret

Get full text

Remission after CAR T‐cell therapy: Do lymphoma patients recover a normal life? by Alya Perthus, Fanny Colin, Emilie Charton, Amélie Anota, Faustine Lhomme, Guillaume Manson, Sophie De Guibert, Pierre Daufresne, Adeline Bellec, Laetitia Le Bars, Sandra De Barros, Loïc Ysebaert, Marianne Merceur, Mélanie Cogné, Thierry Lamy De La Chapelle, Roch Houot, Aline Moignet

Get full text

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies by Hermann Einsele, Javier Briones, Fabio Ciceri, Irene García-Cadenas, Fred Falkenburg, Natacha Bolaños, H.M. Mirjam Heemskerk, Roch Houot, Michael Hudecek, Franco Locatelli, Kate Morgan, C. Emma Morris, Michael O’Dwyer, Jordi Sierra Gil, Marcel van den Brink, Arjan A. van de Loosdrecht

Get full text

The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies by Hermann Einsele, Javier Briones, Fabio Ciceri, Irene García Cadenas, Fred Falkenburg, Natacha Bolaños, H.M. Mirjam Heemskerk, Roch Houot, Michael Hudecek, Franco Locatelli, Kate Morgan, Emma C. Morris, Michael O’Dwyer, Jordi Gil Sierra, Marcel van den Brink, Arjan A. van de Loosdrecht

Get full text

P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY. by Clementine Sarkozy, Catherine Thieblemont, Lucie Oberic, Anne Moreau, Kamal Bouabdallah, Gandhi Laurent Damaj, Thomas Gastinne, Vincent Ribrag, Rene Olivier Casasnovas, Corinne Haioun, Roch Houot, Fabrice Jardin, Eric Van Den Neste, Morgane Cheminant, Franck Morschhauser, Mary Callanan, Herve Ghesquieres, Remy Gressin, Olivier Hermine, Steven Le Gouill

Get full text